Canada markets close in 10 minutes

Appili Therapeutics Inc. (APLI.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.03000.0000 (0.00%)
As of 02:26PM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.64M
Enterprise Value 13.39M
Trailing P/E N/A
Forward P/E 2.38
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.40
Price/Book (mrq)N/A
Enterprise Value/Revenue 16.18
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.98
52-Week Change 3-45.45%
S&P500 52-Week Change 320.52%
52 Week High 30.0800
52 Week Low 30.0250
50-Day Moving Average 30.0357
200-Day Moving Average 30.0351

Share Statistics

Avg Vol (3 month) 391.15k
Avg Vol (10 day) 316.91k
Shares Outstanding 5121.27M
Implied Shares Outstanding 6121.27M
Float 8106.83M
% Held by Insiders 10.06%
% Held by Institutions 111.84%
Shares Short (Aug 15, 2024) 489.38k
Short Ratio (Aug 15, 2024) 40.04
Short % of Float (Aug 15, 2024) 4N/A
Short % of Shares Outstanding (Aug 15, 2024) 40.07%
Shares Short (prior month Jul 15, 2024) 47.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,039.88%

Management Effectiveness

Return on Assets (ttm)-244.22%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)827.41k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.59M
Net Income Avi to Common (ttm)-3.82M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)301.26k
Total Cash Per Share (mrq)0
Total Debt (mrq)10.05M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.16
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-572.66k
Levered Free Cash Flow (ttm)-5.77M